1. Home
  2. EDSA vs AEMD Comparison

EDSA vs AEMD Comparison

Compare EDSA & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • AEMD
  • Stock Information
  • Founded
  • EDSA 2015
  • AEMD 1984
  • Country
  • EDSA Canada
  • AEMD United States
  • Employees
  • EDSA N/A
  • AEMD N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • AEMD Medical/Dental Instruments
  • Sector
  • EDSA Health Care
  • AEMD Health Care
  • Exchange
  • EDSA Nasdaq
  • AEMD Nasdaq
  • Market Cap
  • EDSA 6.2M
  • AEMD 6.7M
  • IPO Year
  • EDSA N/A
  • AEMD N/A
  • Fundamental
  • Price
  • EDSA $1.96
  • AEMD $0.37
  • Analyst Decision
  • EDSA Strong Buy
  • AEMD Strong Buy
  • Analyst Count
  • EDSA 1
  • AEMD 1
  • Target Price
  • EDSA $21.00
  • AEMD $7.00
  • AVG Volume (30 Days)
  • EDSA 34.1K
  • AEMD 165.7K
  • Earning Date
  • EDSA 05-14-2025
  • AEMD 06-26-2025
  • Dividend Yield
  • EDSA N/A
  • AEMD N/A
  • EPS Growth
  • EDSA N/A
  • AEMD N/A
  • EPS
  • EDSA N/A
  • AEMD N/A
  • Revenue
  • EDSA N/A
  • AEMD N/A
  • Revenue This Year
  • EDSA N/A
  • AEMD N/A
  • Revenue Next Year
  • EDSA N/A
  • AEMD N/A
  • P/E Ratio
  • EDSA N/A
  • AEMD N/A
  • Revenue Growth
  • EDSA N/A
  • AEMD N/A
  • 52 Week Low
  • EDSA $1.55
  • AEMD $0.24
  • 52 Week High
  • EDSA $5.59
  • AEMD $1.06
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 35.93
  • AEMD 44.29
  • Support Level
  • EDSA $1.96
  • AEMD $0.38
  • Resistance Level
  • EDSA $2.06
  • AEMD $0.40
  • Average True Range (ATR)
  • EDSA 0.10
  • AEMD 0.03
  • MACD
  • EDSA -0.00
  • AEMD -0.00
  • Stochastic Oscillator
  • EDSA 30.77
  • AEMD 26.67

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Share on Social Networks: